Molecular basis of colorectal cancer
Batistatou, A.; Charalabopoulos, A.; Charalabopoulos, K.
New England Journal of Medicine 362(13): 1246; Author Reply 1246-1247
2010
ISSN/ISBN: 0028-4793 PMID: 20364460 Document Number: 641752
Document emailed within 1 workday
Related Documents
Pan, G. 1996: Molecular basis of colorectal carcinomas Zhonghua Nei Ke Za Zhi 35(7): 435-436Effendi-Ys, R. 2017: Cancer Stem Cells and Molecular Biology Test in Colorectal Cancer: Therapeutic Implications Acta Medica Indonesiana 49(4): 351-359
Yeh, C-Sheng.; Wang, J-Yuan.; Wu, C-Han.; Chong, I-Wen.; Chung, F-Yen.; Wang, Y-Hsin.; Yu, Y-Ping.; Lin, S-Ru. 2006: Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel International Journal of Oncology 28(2): 411-420
Laurent-Puig, P. 1997: Molecular techniques in the detection of colorectal cancer Gastroenterologie Clinique et Biologique 21(10): 751-753
Chen, Z.Y.; Wang, X.; Wu, T.; Liu, Y.C.; Wang, P.Y. 2017: Progress of molecular subtypes of colorectal cancer Zhonghua Zhong Liu Za Zhi 39(9): 641-645
Kato, S. 2013: New molecular-targeted agents for colorectal cancer - regorafenib and aflibercept Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(1): 6-9
Tenner, L.L.; O'Neil, B.H. 2014: Colorectal cancer and molecular targeted agents: progress--with caveats Oncology 28(2): 125; 128
Deng, Y. 2015: Molecular phenotypes of colorectal cancer is critical in clinical individual treatment Zhonghua Wei Chang Wai Ke Za Zhi 18(10): 994-997
Hibi, K.; Robinson, C.R.; Booker, S.; Wu, L.; Hamilton, S.R.; Sidransky, D.; Jen, J. 1998: Molecular detection of genetic alterations in the serum of colorectal cancer patients Cancer Research 58(7): 1405-1407
Grothey, A. 2006: Recognizing and managing toxicities of molecular targeted therapies for colorectal cancer Oncology 20(14 Suppl 10: 21-28
Ramesar, R.S.; Madden, M.V.; Felix, R.; Harocopos, C.J.; Westbrook, C.A.; Jones, G.; Cruse, J.P.; Goldberg, P.A. 2000: Molecular genetics improves the management of hereditary non-polyposis colorectal cancer South African Medical Journal 90(7): 709-714
Barbarosos, A.; Biacchi, D.; Bolognese, A.; Galati, G.; Izzo, L.; Risuleo, G.; Tartaglia, E. 2005: Molecular epidemiologic analysis of the levels of metalloproteases and cyclooxygenase-2 in colorectal cancer I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 4(3): S206
Biasco, G.; Pantaleo, M. 2001: Molecular biology and the clinical management of patients with hereditary colorectal cancer syndromes Tumori 87(1 Suppl 1: S13-S14
Al-Hajeili, M.; Shields, A.F.; Hwang, J.J.; Wadlow, R.C.; Marshall, J.L. 2017: Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer Oncology 31(4): 301-312
Biasco, G.; Pantaleo, M. 2001: Molecular biology and the clinical management of patients with hereditary colorectal cancer syndromes Tumori 87(1 Suppl 1: S13-S14
Irmejs, A.; Borosenko, V.; Melbarde-Gorkusa, I.; Gardovskis, A.; Bitina, M.; Kurzawski, G.; Suchy, J.; Gorski, B.; Gardovskis, J. 2007: Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia Anticancer Research 27(1b): 653-658
Castorina, S.; Barresi, V.; Luca, T.; Privitera, G.; Musso, Nò.; Capizzi, C.; Condorelli, D.Filippo. 2010: Recent advances in molecular diagnostics of colorectal cancer by genomic arrays: proposal for a procedural shift in biological sampling and pathological report Italian Journal of Anatomy and Embryology 115(1-2): 39-45
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Ishida, H.; Fujioka, M.; Ohsawa, T.; Takeuchi, I.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2001: Effect of peroral doxifluridine plus hepatic arterial infusion for synchronous liver metastasis of colorectal cancer--correlation with the expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in primary colorectal cancer lesions Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1624-1627